Recruiting Recurrent Pregnancy Loss Studies in Los Angeles
About Recurrent Pregnancy Loss Clinical Trials in Los Angeles
Recurrent pregnancy loss is defined as two or more failed pregnancies and affects about 1-2% of couples trying to conceive. Causes include chromosomal abnormalities, uterine anomalies, and immune factors. Treatment depends on the underlying cause and may include hormonal support, surgery, or immunotherapy.
There are currently 3 recurrent pregnancy loss clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 7,865 participants. Research is being sponsored by Société Internationale d'Urologie, Rivermark Medical, Crinetics Pharmaceuticals Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Recurrent Pregnancy Loss Clinical Trials in Los Angeles — FAQ
Are there recurrent pregnancy loss clinical trials in Los Angeles?
Yes, there are 3 recurrent pregnancy loss clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What recurrent pregnancy loss treatments are being tested?
The 3 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for recurrent pregnancy loss.
Data updated October 15, 2026 from ClinicalTrials.gov